by inpharmedia | Jan 8, 2025 | Blog, Regulatory
The United States Food and Drug Administration (FDA) plays a crucial role in regulating the approval and marketing of drugs, biologics, and a wide range of other products, including food, pharmaceuticals, medical devices, and cosmetics. Companies and researchers... by inpharmedia | Sep 3, 2022 | Guidances, Regulatory
US FDA has issued a series of guidance’s to assists the sponsor and applicant in the generic drug development. The August month has around 06 new/revised guidance under GDUFA and ICH provisions. The links of the guidance’s are provided below for quick review and...
by inpharmedia | Feb 9, 2020 | Blog, Product Development
What is Inactive Ingredient Database? Inactive Ingredient Database (IIG) Database is a collection and aligned set of inactive ingredients, that are to be present or appeared in FDA approved drug products, allowing industry to access for development of new products....
